Skip to main content
Caplight Logo









Nvision Biomedical Technologies

Nvision Biomedical Technologies

Private
San Antonio, TexasHealthcare & Life Scienceshttps://nvisionbiomed.com/

Last Round

Series B

May 13, 2026

Est. Valuation

$250M

Total Funding Raised

$55.25M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nvision Biomedical Technologies is a medical devices company that provides surgeons with implants paired with instrumentation and biologics to simplify and improve surgery procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

orthopedic implantsmedical devicesspinal implantsadditive manufacturing3D printed implantsfoot and ankle reconstructionMedTechPEEK implantsspinal fusionadvanced materialsbiologicssurgical instrumentationtitanium implantsallograftambulatory surgery centersASCsbioskills lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nvision Biomedical Technologies Comparables

Compare Nvision Biomedical Technologies with similar companies based on industry and business-model similarity.

Nvision Biomedical Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
4WEB Medical
85%
Zavation Medical Products
82%
Curiteva, Inc.
78%

Nvision Biomedical Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 13, 2026
DebtApr 28, 2020
SeedSep 18, 2017

Key People

Founding team and executive leadership

Dominic Duran

Chief Financial Officer

Executive Team

Nvision Biomedical Technologies Investors

Notable investors and investment history

Nvision Biomedical Technologies investors
InvestorRounds
Entrée CapitalSeries B
European Investment Bank GroupSeries B
CDP Venture Capital SGRSeries B
JPMorgan Chase & Co.Debt
Playground GlobalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 73% MoM, reaching 2.6K.

  • May 13, 2026

    $55M round led by Abbott Laboratories.

Nvision Biomedical Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nvision Biomedical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nvision Biomedical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Antonio, Texas
Employee Range25
Year Founded2013
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?